Gene and cell therapy facility establishes in Berlin
A New Beacon of Hope: The Translation Center for Gene and Cell Therapies in Berlin
In the heart of Berlin, a significant milestone is being achieved with the construction of the Translation Center for Gene and Cell Therapies. This new center, located in Berlin-Mitte, is the first central building block of a Life Science Campus in the city.
The groundbreaking ceremony, attended by Berlin's Governing Mayor Kai Wegner (CDU), marked the official start of the project. The Translation Center, a ten-story building with approximately 20,000 square meters of total area, is being constructed on the Bayer campus at the Berlin North Harbor.
The primary focus of the Translation Center is on gene and cell therapies, which hold promise for people who have not responded to conventional therapies or for whom there is currently no effective treatment. Charité, Bayer AG, and the Berlin Institute of Health at Charité, in collaboration with the German Center for Child and Adolescent Health (DZKJ), are the primary partners in this project. The project is primarily funded by the federal government and the state of Berlin.
The Translation Center will not only serve as a research hub but also as a production facility for the development of gene and cell therapeutics up to clinical phase II. It is expected to offer space for 15 to 20 start-ups at different stages of development.
In addition to the Berlin Center for Gene and Cell Therapies (BC GCT), other tenants are expected to move into the Translation Center. This development is seen as a significant step towards building a life science campus in Berlin, offering hope for countless individuals who are in need of innovative treatments.
The Translation Center will focus on transferring research findings into healthcare, bridging the gap between laboratory discoveries and real-world applications. With its construction underway, Berlin is poised to become a leading hub for gene and cell therapies, contributing to groundbreaking advancements in healthcare.